In addition, genetic variants at the LRRK2 and PARK16 loci seem to impact upon PD risk in a non-additive manner (MacLeod et al., 2013; Pihlstrom et al., 2015), suggesting a common mechanism of action. This evidence concerns the gene LRRK2 and Parkinson disease.